Similar articles

• [AT1 blocker or calcium antagonist in treatment of hypertension. What protects the heart better?].

  Einecke D. Einecke D. MMW Fortschr Med. 2004 Jun 24;146(26):12. MMW Fortschr Med. 2004. PMID: 15529682 German. No abstract available.
• [VALUE study underscores the importance of reaching goal blood pressure values for minimization of cardiovascular risks].

  [No authors listed] [No authors listed] Praxis (Bern 1994). 2004 Oct 27;93(44):1836. Praxis (Bern 1994). 2004. PMID: 15559910 German. No abstract available.
• [VALUE].

  Okura T, Higaki J. Okura T, et al. Nihon Rinsho. 2006 Aug;64 Suppl 6:419-24. Nihon Rinsho. 2006. PMID: 16981573 Review. Japanese. No abstract available.
• [Preventing end-organ damage in hypertension. What is the significance of the VALUE Study for general practice?].

  Zidek W. Zidek W. MMW Fortschr Med. 2004 Jul 8;146(27-28):41. MMW Fortschr Med. 2004. PMID: 15526662 German. No abstract available.
• Single-pill combination of amlodipine and valsartan in the management of hypertension.

  Flack JM, Hilkert R. Flack JM, et al. Expert Opin Pharmacother. 2009 Aug;10(12):1979-94. doi: 10.1517/14656560903120899. Expert Opin Pharmacother. 2009. PMID: 19606937 Review.